M42 has entered Africa through a 10-year strategic partnership with Botswana’s Ministry of Health, marking the healthcare company’s first health systems partnership on the continent.

The partnership will support Botswana’s digital health transformation, national genomics programme, precision medicine and local capacity development. M42 and Mubadala Bio will also collaborate on pharmaceutical and medical equipment supply to strengthen the country’s medical supply chain and improve access to essential healthcare products.

Click here to join our WhatsApp channel here

The agreement aligns with Botswana’s efforts to achieve Universal Health Coverage and aims to build a more resilient, sustainable and technology-enabled healthcare system. M42 will bring its expertise in AI, digital health, genomics and precision medicine to support the country’s long-term healthcare transformation.

Commenting on the agreement, Dimitris Moulavasilis, Group Chief Executive of M42, said: “M42 has been accelerating our efforts to showcase our healthcare capabilities across the Global South, where we see a distinct opportunity for nations to leapfrog legacy systems and build digital and AI native health systems that are prevention first. This agreement marks our entry into Africa and presents an opportunity to deploy our full capabilities across digital health transformation, genomics, precision medicine and capacity development to help serve the people of Botswana in partnership with the country’s Ministry of Health.”

Also read: Medical Residents Explore Humanoid Robots and Innovation in Patient Care

Kareem Shahin, Chief Executive Officer, Digital Health Solutions Platform and Group Chief Digital Officer of M42, said: ” It is a privilege to stand alongside the Ministry of Health of Botswana as a long-term partner in the country’s health transformation. We support the Ministry’s commitment to a health system that every citizen can rely on, where medicines are available, technologies work and care reaches every community. “